These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

119 related items for PubMed ID: 4612055

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Plasma concentrations of L-dopa and 3-methoxydopa and improvement in clinical ratings and motor performance in patients with Parkinsonism treated with L-dopa alone or in combination with amantadine.
    Pilling JB, Baker J, Iversen LL, Iversen SD, Robbins T.
    J Neurol Neurosurg Psychiatry; 1975 Feb; 38(2):129-35. PubMed ID: 1097598
    [Abstract] [Full Text] [Related]

  • 3. Treatment of Parkinson's Disease with levodopa and amantadine used as single drugs and in combined therapy.
    Callagham N, Mcllroy M, O'Connor M.
    Ir J Med Sci; 1974 Mar; 143(2):67-78. PubMed ID: 4617744
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Four-year treatment of patients with parkinsonism using amantadine alone or with levodopa.
    Timberlake WH, Vance MA.
    Ann Neurol; 1978 Feb; 3(2):119-28. PubMed ID: 350129
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. The L-dopa sparing effect of G 31,406 in the treatment of parkinson's disease.
    Couto B, Oliveira C, Mattos JP, Freitas MR.
    Neurol Neurocir Psiquiatr; 1976 Feb; 17(4):285-92. PubMed ID: 798128
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Long-term therapy of Parkinson's disease with amantadine, alone and combined with levodopa.
    Zeldowicz LR, Hubermann J.
    Can Med Assoc J; 1973 Oct 06; 109(7):588-93. PubMed ID: 4582563
    [Abstract] [Full Text] [Related]

  • 15. Amantadine and a fixed combination of carbidopa and levodopa in parkinsonism: a preliminary report.
    Savery F.
    Curr Ther Res Clin Exp; 1976 Mar 06; 19(3):337-8. PubMed ID: 817863
    [No Abstract] [Full Text] [Related]

  • 16. Clinical evaluation of amantadine therapy for parkinsonism and the side effects--in cases of thalamic surgery and L-dopa therapy.
    Matsumoto K, Omoto T, Beck H.
    Folia Psychiatr Neurol Jpn; 1974 Jan 06; 28(1):1-10. PubMed ID: 4406943
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.